How big is the South Africa In-Vitro Diagnostics Market?

The South Africa In-Vitro Diagnostics Market size is expected to reach USD 1.46 billion in 2024 and grow at a CAGR of 5.01% to reach USD 1.87 billion by 2029. Read More

What is the current South Africa In-Vitro Diagnostics Market size?

In 2024, the South Africa In-Vitro Diagnostics Market size is expected to reach USD 1.46 billion. Read More

Who are the key players in South Africa In-Vitro Diagnostics Market?

Nihon Kohden Corporation, Siemens Healthineers, Thermo Fisher Scientific, Abbott Laboratories and F. Hoffmann-La Roche Ltd are the major companies operating in the South Africa In-Vitro Diagnostics Market. Read More

What years does this South Africa In-Vitro Diagnostics Market cover, and what was the market size in 2023?

In 2023, the South Africa In-Vitro Diagnostics Market size was estimated at USD 1.39 billion. The report covers the South Africa In-Vitro Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the South Africa In-Vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

South Africa In-Vitro Diagnostics Market Share

Statistics for the 2023 & 2024 South Africa In-Vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. South Africa In-Vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of South Africa In-Vitro Diagnostics Industry

The In-vitro Diagnostics market in South Africa is fragmented in nature. This is majorly due to the rising investment of global companies in South Africa as this country shows several opportunities for growth. With the rising expansion strategies that are being implemented by the companies, it is expected that in the future, several small and mid-sized companies will penetrate the market and hold a substantial share. The major players in the market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Thermo Fisher Scientific, and Nihon Kohden Corporation among others.